Corvus Pharmaceuticals, Inc. (CRVS) Misses Q3 EPS by 49c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: CRVS) | Delayed: 10.65 +0.60 (5.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.05 | 52 Week High | $17.77 | |||
| Open | $9.92 | 52 Week Low | $9.63 | |||
| Day High | $10.68 | P/E | N/A | |||
| Day Low | $9.85 | EPS | $0.00 | |||
| Volume | 1,080,550 | |||||
